SCHEMBL6707946

SCHEMBL6707946

CC(=O)Nc1ccc(-c2cc3onc(C(=O)Nc4ccc(Cl)cc4-c4noc(=O)[nH]4)c3cc2NC(C)=O)c(C(F)(F)F)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIK1 P39086 1/20 0.42
HIF1A Q16665 3/20 0.36
MAP2K1 Q02750 1/20 0.35
ABL1 P00519 1/20 0.34
HDAC1 Q13547 1/20 0.34
TMPRSS4 Q9NRS4 3/20 0.34
CA12 O43570 1/20 0.34
CA9 Q16790 1/20 0.34
TRPV1 Q8NER1 1/20 0.33
S1PR1 P21453 1/20 0.33
S1PR3 Q99500 1/20 0.33
KDM4E B2RXH2 2/20 0.33
MEN1 O00255 1/20 0.33
ALDH1A1 P00352 1/20 0.33
TP53 P04637 1/20 0.33
HPGD P15428 1/20 0.33
KMT2A Q03164 1/20 0.33
HSD17B10 Q99714 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
F11 P03951 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6710154 0.92 GRIK1 (0.40) GRIK1HIF1AMAP2K1ABL1HDAC1
SCHEMBL6708767 0.87 HIF1A (0.35) HIF1AMAP2K1HDAC1TMPRSS4CA12
SCHEMBL6711456 0.85 HIF1A (0.46) GRIK1HIF1AHDAC1KDM4EMEN1
SCHEMBL6710398 0.81 LMNA (0.37) GRIK1HIF1AMEN1ALDH1A1TP53
SCHEMBL6709033 0.79 HIF1A (0.49) GRIK1HIF1AALDH1A1KMT2AF11
SCHEMBL6709153 0.78 EPHX2 (0.43) GRIK1HIF1ACA12CA9KDM4E
SCHEMBL6711801 0.78 HIF1A (0.43) GRIK1HIF1ACA12CA9KDM4E
SCHEMBL6833746 0.78 KCNK2 (0.39) HIF1AMAP2K1S1PR1S1PR3KDM4E
SCHEMBL6833974 0.78 TAS2R14 (0.42) GRIK1HIF1AMAP2K1CA12CA9
SCHEMBL6753986 0.77 RORC (0.32) MAP2K1S1PR1S1PR3TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 GRIK1 3885/4885HIF1A 296/4885MAP2K1 4678/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.